ArticleAnnals of the rheumatic diseases2006

Infliximab leads to a rapid but transient improvement in endothelial function in patients with primary systemic vasculitis.

K Raza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.